Cord Blood Education and Awareness Act of 2009 [HB-2107]
Cord Blood Education and Awareness Act of 2009 - Requires the Secretary of Health and Human Services (HHS) to develop a publication relating to umbilical cord blood that includes: (1) an explanation of the potential value and uses of umbilical cord blood; (2) the medical processes involved in the collection of cord blood; and (3) options for ownership and future use of donated umbilical cord blood. Directs the Secretary to develop a written patient informed consent document relating to cord blood disposition to be presented to and signed by the
(continued...)
HB-2107: Cord Blood Education and Awareness Act of 2009
Sponsored by: Rep. Jackie Speier
Referred To The Subcommittee On Health, Employment, Labor, And Pensions. on 06/04/2009
You have voted HB-1718: To amend the Internal Revenue Code of 1986 to treat amounts paid for umbilical cord blood banking services as medical care expenses..
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 [HB-1458]
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009 - Amends SSA title II (Old Age, Survivors and Disability Insurance) (OASDI) to: (1) continue entitlement to prescription drugs used in immunosuppressive therapy furnished to an individual who receives a kidney transplant for which payment is made under Medicare; and (2) extend Medicare secondary payer requirements for end stage renal disease (ESRD) beneficiaries. Amends title XVIII (Medicare ) of SSA to apply special rules to kidney transplant recipients receiving
(continued...)
HB-1458: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Sponsored by: Rep. Steve Scalise
Referred To The Subcommittee On Health, Employment, Labor, And Pensions. on 04/29/2009
Access to America's Orthopaedic Services Act of 2009 [HB-1021]
Access to America's Orthopaedic Services Act of 2009 - Requires the Secretary of Health and Human Services to establish criteria for accounting and reporting the effort expended by researchers on musculoskeletal research funded with certain grants.Sets forth reporting requirements related to musculoskeletal health, including on: (1) research funded by the National Institutes of Health (NIH); (2) federal programs and activities relating to musculoskeletal trauma care; (3) a standard unit for the measurement of bone mass under the Medicare program;
(continued...)
HB-1021: Access to America's Orthopaedic Services Act of 2009
Sponsored by: Rep. Ted Poe
Referred To The Subcommittee On Technology And Innovation. on 02/25/2009
TRANSPLANT Act of 2020 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 [S.4672]
Modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies. Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the
(continued...)
S.4672: TRANSPLANT Act of 2020 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
Sponsored by: Sen. Jack Reed
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 09/23/2020
Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act [S.4574]
Requires the Centers for Medicare & Medicaid Services (CMS) to establish a demonstration program for Medicare beneficiaries with end-stage renal disease (ESRD). Under the program, renal dialysis facilities, kidney disease specialists, physician practices, and other health care practitioners may form an organization that partners with certain health care entities to provide integrated care to beneficiaries with ESRD. Such care must include all covered Medicare benefits as well as transition services for transplantations, palliative care, and hospice.
(continued...)
S.4574: Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act
Sponsored by: Sen. Marsha Blackburn
Read Twice And Referred To The Committee On Finance. on 09/15/2020
BETTER Kidney Care Act Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act [HB-8254]
Requires the Centers for Medicare & Medicaid Services (CMS) to establish a demonstration program for Medicare beneficiaries with end-stage renal disease (ESRD). Under the program, renal dialysis facilities, kidney disease specialists, physician practices, and other health care practitioners may form an organization that partners with certain health care entities to provide integrated care to beneficiaries with ESRD. Such care must include all covered Medicare benefits as well as transition services for transplantations, palliative care, and hospice.
(continued...)
HB-8254: BETTER Kidney Care Act Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act
Sponsored by: Rep. Barbara Lee
Introduced In House on 09/15/2020
Organ Donation Clarification Act of 2020 [HB-7900]
Specifies that certain payments and pilot programs relating to organ donation do not violate the National Organ Transplant Act, which prohibits the exchange of valuable consideration for human organs. Specifically, it excludes additional types of reimbursements and payments related to organ donation from the definition of valuable consideration, such as costs for (1) dependent care; (2) certain medical expenses for up to 10 years after a donation; (3) paperwork or legal services; and (4) term life insurance policies, subject to some limitations.
(continued...)
HB-7900: Organ Donation Clarification Act of 2020
Sponsored by: Rep. Steve Cohen
Introduced In House on 07/31/2020
Stop Predatory Organ Trafficking Act of 2020 [HB-7805]
Authorizes the imposition of visa-blocking sanctions on a foreign individual who has committed or facilitated the trafficking in persons for the purpose of organ removal. The Department of State must report to foreign ministries the names of individuals convicted of crimes related to organ purchasing for consideration regarding the issuance of visas to such individuals. The State Department must also submit an annual report to Congress that includes descriptions of (1) the sources, practices, methods, facilitators, and recipients of trafficking
(continued...)
HB-7805: Stop Predatory Organ Trafficking Act of 2020
Sponsored by: Rep. Matthew Cartwright
Committee Consideration And Mark-up Session Held. on 07/29/2020
Plasma Donation Awareness Act of 2020 [HB-7783]
To amend the CARES Act to expand a national awareness and outreach campaign to address the importance and safety of plasma donation, and for other purposes.
HB-7783: Plasma Donation Awareness Act of 2020
Sponsored by: Rep. Robin Kelly
Introduced In House on 07/24/2020
Plasma Donation Awareness Act [S.4179]
A bill to update the blood donation public awareness campaign of the Department of Health and Human Services to include public awareness on plasma donation.
S.4179: Plasma Donation Awareness Act
Sponsored by: Sen. Amy Klobuchar
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 07/02/2020
HR-989: Expressing the sense of the House of Representatives that blood donation policies in the United States should be equitable and based on science.
Sponsored by: Rep. Sean Maloney
Introduced In House on 06/01/2020
You have voted HR-989: Expressing the sense of the House of Representatives that blood donation policies in the United States should be equitable and based on science..
Protecting Cures Act of 2020 [HB-6417]
Prohibits the Department of Health and Human Services from withholding funding, because of ethical considerations, for research activities that use human fetal tissue, provided that the research activities have been recommended for approval by an institutional review board and otherwise comply with existing laws concerning human fetal tissue. The bill also establishes that this research is not unethical by deeming the 1988 report of the Human Fetal Tissue Transplantation Research Panel as meeting relevant statutory requirements with respect to approving
(continued...)
HB-6417: Protecting Cures Act of 2020
Sponsored by: Rep. Janice Schakowsky
Introduced In House on 03/31/2020
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020 [S.3353]
Indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant. Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.
S.3353: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020
Sponsored by: Sen. Sheldon Whitehouse
Read Twice And Referred To The Committee On Finance. on 02/27/2020
LOST Organs Act of 2020 Lost Opportunities to Supply Transplantable Organs Act of 2020 [S.3317]
Requires the Organ Procurement and Transplantation Network to take specified actions related to the transportation of organs, including tracking and publically reporting the status of organs in the transplant supply chain. The Organ Procurement and Transplantation Network is a public-private partnership that links the professionals involved in the U.S. donation and transplantation system.
S.3317: LOST Organs Act of 2020 Lost Opportunities to Supply Transplantable Organs Act of 2020
Sponsored by: Sen. Benjamin Cardin
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 02/13/2020
TRANSPLANT Act of 2020 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 [HB-4764]
Modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies. Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the
(continued...)
HB-4764: TRANSPLANT Act of 2020 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
Sponsored by: Rep. Raul Grijalva
Message On Senate Action Sent To The House. on 12/14/2020
S.2063: Organ Procurement Optimization Act of 2019
Sponsored by: Sen. Michael Bennet
Read Twice And Referred To The Committee On Finance. (sponsor Introductory Remarks On Measure: Cr S4732) on 07/09/2019